Tesamorelin/Ipamorelin

Synergistic growth hormone support.

A synergistic combination of Tesamorelin and Ipamorelin for enhanced growth hormone optimization with complementary mechanisms of action.

How it works

Tesamorelin stimulates GH release via GHRH pathway while Ipamorelin acts as a selective ghrelin mimetic, together amplifying natural GH pulsatility without cortisol or prolactin elevation.

Benefits

• Stimulates natural growth hormone release
• Once-daily dosing
• Physician-dosed
• Does not replace hormone directly

Dosing protocol

Daily subcutaneous injection before bedtime. Provider-guided dosing.

Contraindications

• Active cancer
• Pregnancy
• Pituitary disorders

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.